The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Disclosure of Conflicts of Interest – Prof. Jaap Verweij

This is a disclosure report regarding financial/non-financial relationships with for-profit/non-profit healthcare organizations.

Pharmaceutical companies with potential conflict of interest

  • Non-executive medical director: Octimet
  • Stock options: Octimet
  • Honoraria in the last 24 months: Basilea, Genmab, InteRNA, Octimet, and CoBioRes

Other affiliations with potential conflict of interest

  • Board member: American Society of Clinical Oncology
  • Chairman Governance Task Force: European Organisation for Research and Treatment of Cancer (From Feb 2020 onward)


Last updated on 24 May 2020

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70